Jump to content

PDL1


Susanrae

Recommended Posts

Good morning!  I start my immunotherapy tomorrow.  Can anyone give me any insight about side effects with PDL1?  I have a 70% positive expression so I am hopeful that I will have some shrinkage with my Stage IV Lung ca.  Every 3 weeks over a period of 12 weeks I will have an infusion.  Thanks for listening!  Susanrae

 

Link to comment
Share on other sites

Hi Susanrae,

I get fatigue for a few days. There is a forum with many other getting Duvalumab, enter that is a search. https://forums.lungevity.org/topic/44842-durvalumab/

 

There is someone that just reported great success.  Good luck on your journey, please let us know how you do with your infusions and ask anything as someone may know.

Link to comment
Share on other sites

Good to hear you are not having many side effects.  I received on my first infusion of Keytruda on May 13th.  Had a little nausea on the 2nd and 3rd day and some fatigue but that has been it so far.   YAY! 

 

 

 

 

Link to comment
Share on other sites

Susanrae,

Glad to hear that your initial Keytruda side effects were minimal.  My mom began to develop a rash by her 2nd or 3rd infusion.  Rash is one of the most common side effects next to fatigue.  Since Keytruda can be a long journey, I really suggest writing down your side effects after each infusion to keep track.  That way you can quickly identify if something is out of the norm and let your docs know asap.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.